The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2026, according to Statista. The ...

For AstraZeneca, oncology sales now account for 43% of total revenues. Sales in its oncology segment rose 16% year over year ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

As with the many other “most-favored-nation” deals between the White House and large pharmas, the agreement is short on ...

ARCALYST® (rilonacept) 2025 net product revenue of $677.5 million (unaudited), representing ~62% year-over-year growth –– ...

AbbVie Inc.’s founding CEO Richard Gonzalez will step down July 1, the drugmaker said Tuesday, and will be replaced by the company’s current president and chief operating officer, Robert Michael.

ARCALYST- (rilonacept) 2025 net product revenue of $677.5 million (unaudited), representing ~62% year-over-year growth -- ARCALYST 2026 net product revenue expected to be $900 - $920 million -- KPL-38 ...